Field evaluation of SD BIOLINE HIV/Syphilis Duo assay among pregnant women attending routine antenatal care in Juba, South Sudan
Open Access
- 10 October 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205383
Abstract
The SD BIOLINE HIV/Syphilis Duo assay is the first World Health Organization prequalified dual rapid diagnostic test for simultaneous detection of HIV and Treponema pallidum antibodies in human blood. Prior to introducing the test into antenatal clinics across South Sudan, a field evaluation of its clinical performance in diagnosing both HIV and syphilis in pregnant women was conducted. SD Bioline test performance on venous blood samples was compared with (i) Vironostika HIV1/2 Uniform II Ag/Ab reference standard and Alere Determine HIV 1/2 non-reference standard for HIV diagnosis, and (ii) Treponema pallidum hemagglutination reference standard and Rapid plasma reagin non-reference standard for syphilis. Sensitivity, specificity, positive predictive value (PPN), negative predictive value (NPV) and kappa (κ) value were calculated for each component against the reference standards within 95% confidence intervals (CIs); agreements between Determine HIV 1/2 and SD Bioline HIV tests were also calculated. Of 442 pregnant women recruited, eight (1.8%) were HIV positive, 22 (5.0%) had evidence of syphilis exposure; 14 (3.2%) had active infection. For HIV diagnosis, the sensitivity, specificity, PPV and NPV were 100% (95% CI: 63.1–100), 100% (95% CI: 99.2–100), 100% (95% CI: 63.1–100) and 100% (95% CI: 99.2–100) respectively with κ value of 1 (95% CI: 0.992–1.000). Overall agreement of the Duo HIV component and Determine test was 99.1% (95% CI: 0.977–0.998) with 66.7% (95% CI: 34.9–90.1) positive and 100% (95% CI: 0.992–1.000) negative percent agreements. For syphilis, the Duo assay sensitivity was 86.4% (95% CI: 65.1–97.1) and specificity 100% (95% CI: 99.1–100) with PPV 100% (95% CI: 82.4–100), NPV 99.2% (95% CI: 97.9–99.9) and κ value 0.92 (95% CI: 0.980–0.999). Our findings suggest the SD Bioline HIV/Syphilis Duo Assay could be suitable for HIV and syphilis testing in women attending antenatal services across South Sudan. Women with positive syphilis results should receive treatment immediately, whereas HIV positive women should undergo confirmatory testing following national HIV testing guidelines.Keywords
This publication has 25 references indexed in Scilit:
- NovelTreponema pallidumSerologic Tests: A Paradigm Shift in Syphilis Screening for the 21st CenturyClinical Infectious Diseases, 2010
- Syphilis screening among female sex workers in Bangalore, India: comparison of point-of-care testing and traditional serological approachesSexually Transmitted Infections, 2009
- Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programmeBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- Field evaluation of the performance and testing costs of a rapid point-of-care test for syphilis in a red-light district of Manaus, BrazilSexually Transmitted Infections, 2008
- Cost-Effectiveness of Rapid Syphilis Screening in Prenatal HIV Testing Programs in HaitiPLOS Medicine, 2007
- Syphilis and HIV Infection: An UpdateClinical Infectious Diseases, 2007
- A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived seraSexually Transmitted Infections, 2006
- Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilisSexually Transmitted Infections, 2006
- Syphilis in Pregnancy in Tanzania. I. Impact of Maternal Syphilis on Outcome of PregnancyThe Journal of Infectious Diseases, 2002
- High agreement but low Kappa: I. the problems of two paradoxesJournal of Clinical Epidemiology, 1990